IFP Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

IFP Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-362	Closed	-$4.31K	–	2989
2020 Q1	$4K	Sell	362 -4,314	-92%	-$60.3K	﹤0.01%	2188
2019 Q4	$116K	Hold	4,676	–	–	0.01%	875
2019 Q3	$67K	Buy	+4,676	New	+$68.6K	﹤0.01%	1237
2019 Q1	$53K	Buy	+3,027	New	+$45.1K	0.01%	947
2018 Q4	–	Sell	-156	Closed	-$3K	–	3913
2018 Q3	$3K	Buy	156 +45	+41%	+$1.37K	﹤0.01%	3463
2018 Q2	$5K	Buy	111 +55	+98%	+$2.52K	﹤0.01%	3294
2018 Q1	$4K	Hold	56	–	–	﹤0.01%	3303
2017 Q4	$4K	Buy	+56	New	+$4.63K	﹤0.01%	3352
2016 Q2	–	Sell	-3,027	Closed	-$53K	–	4112
2016 Q1	$53K	Buy	+3,027	New	+$614K	0.01%	946

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

IFP Advisors's LUMO Position: Q2 2020 in Review

IFP Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2020, closing a stake of 362 shares — an estimated $4.31K sold.

IFP Advisors first reported a position in LUMO in Q1 2016 and held it in 9 quarters. The position peaked at $116K in Q4 2019. 43 funds tracked by Wall St. Rank hold LUMO as of Q2 2020.

IFP Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
IFP Advisors sold 362 Lumos Pharma, Inc. Common Stock shares in Q2 2020, an estimated $4.31K.
IFP Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2016 and held it in 9 quarters.
IFP Advisors's Lumos Pharma, Inc. Common Stock position peaked at $116K in Q4 2019.
43 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2020.

Based on IFP Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.